The World Health Organization has temporarily paused the use of anti-malaria drug hydroxychloroquine as part of a global effort to find a cure for Covid-19.
The organisation’s executive board made the decision following a study published in the medical journal The Lancet on 20 May that showed that the drug increased mortality rates among Covid-19 patients.
“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” the head of the WHO Dr Tedros Ghebreyesus told journalists in a virtual press briefing.
He said the other arms of the trial were continuing.
Hydroxycholoroquine has been touted by US President Donald Trump and other leaders as a possible treatment for Covid-19.
more recommended stories
US President Trump says ‘terrible decision’ to keep schools shut
US President Donald Trump has criticised.
Zindzi Mandela, daughter of Nelson and Winnie, dies at 59
Zindzi Mandela, the daughter of South.
China defends WHO, lashes out at US move to withdraw
BEIJING — China defended the World.
4,173 deaths in Scotland now linked to Covid-19
A total of 4,173 Scots deaths.
Nigeria state doctors strike over poor coronavirus management
Doctors in Cross River state in.
Kanye West declares he’s running for president in upcoming 2020 election
WASHINGTON (Reuters) – American rapper Kanye.